ArticleCancer chemotherapy and pharmacology2024

Gene polymorphisms of TACR1 serve as the potential pharmacogenetic predictors of response to the neurokinin-1 receptor antagonist-based antiemetic regimens: a candidate-gene association study in breast cancer patients.

Marziyeh Ghorbani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.